Concept
Cancer Progress
Cancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute / Progress Is Real, But Uneven
"From 1991 to 2023, the cancer death rate declined by 34%, translating to an estimated 4.8 million deaths averted. This progress stems from a variety of factors, including reduced smoking, earlier detection, and improved treatments—including the immunotherapy revolution. Despite decades of advancement, the report also highlights areas where progress has been slower and uneven—underscoring the need for continued research and innovation."
Related Ideas
- Research ProgressCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · The Road Ahead
- Cancer ChallengesCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · The Road Ahead
- Survival GainsCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Immunotherapy Is Helping Rewrite Survival Curves
- Immunotherapy ReachCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · What the Report Means for Immunotherapy
- Early DetectionCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · What the Report Means for Immunotherapy
- Geographic GapsCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Progress Is Real, But Uneven
- Health InequitiesCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · Progress Is Real, But Uneven
- Research FundingCancer in 2026: How Immunotherapy Is Reshaping the Odds - Cancer Research Institute · What the Report Means for Immunotherapy